A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus

Markus Suckfüll; Michael Althaus; Barbara Ellers-Lenz; Alexander Gebauer; Roman Görtelmeyer; Pawel J Jastreboff; Hans J Moebius; Tanja Rosenberg; Hermann Russ; Yvonne Wirth; Hagen Krueger

doi:10.1186/1472-6815-11-1

Download references

A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus

Markus Suckfüll^*, Michael Althaus, Barbara Ellers-Lenz, Alexander Gebauer, Roman Görtelmeyer, Pawel J Jastreboff, Hans J Moebius, Tanja Rosenberg, Hermann Russ, Yvonne Wirth and Hagen Krueger

* Corresponding author: Markus Suckfüll markus.suckfuell@med.uni-muenchen.de

BMC Ear, Nose and Throat Disorders 2011, 11:1 doi:10.1186/1472-6815-11-1

Include	Article citation and all cited references Cited references only Article citation only
Format	EndNote, Zotero or Papers Reference Manager Refworks BibTeX

BMC Ear, Nose and Throat Disorders

Viewing options

Associated material

Tools

Share this article

Download references

A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus

BMC Ear, Nose and Throat Disorders

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Download references

A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus